[1]
|
G. Reider, J. A. Hofmann, R. A. Hatz, M. Stolte and G. A. Enders, “Up-Regulation of Inducible Nitric Oxide Synthase in Helicobacter pylori-Associated Gastritis May Represent an Increased Risk Factor to Develop Gastric Carcinoma of the Intestinal Type,” International Journal of Medical Microbiology, Vol. 293, No. 6, 2003, pp. 403412. doi:10.1078/1438-4221-00280
|
[2]
|
S. Backert and M. Neumann, “What a Disorder: Proinflammatory Signaling Pathways Induced by Helicobacter pylori,” Trends in Microbiology, Vol. 18, No. 11, 2010, pp. 479-486. doi:10.1016/j.tim.2010.08.003
|
[3]
|
B. Bauer and T. F. Meyer, “The human Gastric Pathogen Helicobacter pylori and Its Association with Gastric Cancer and Ulcer Disease,” Ulcers, Vol. 2011, 2011, 23 Pages, Article ID 340157. doi:10.1155/2011/340157
|
[4]
|
L. A. Wroblewski, R. M. Peek and K. T. Wilson, “Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk,” Clinical Microbiology Reviews, Vol. 23, No. 4, 2010, pp. 713-739.
doi:10.1128/CMR.00011-10
|
[5]
|
B. L. Slomiany and A. Slomiany, “Role of Constitutive Nitric Oxide Synthase in Regulation of Helicobacter pylori-Induced Gastric Mucosal Cyclooxygenase-2 Activation through S-Nitrosylation: Mechanism of Ghrelin Action,” Open Journal of Gastroenterology, Vol. 1, No. 2, 2011, pp. 13-22. doi:10.4236/ojgas.2011.12003
|
[6]
|
B. L. Slomiany and A. Slomiany, “Role of Ghrelin Induced cSrc activation in Modulation of Gastric Mucosal Inflammatory Responses to Helicobacter pylori,” Inflammopharmacology, Vol. 19, No. 4, 2011, pp. 197-204.
doi:10.1007/s10787-011-0083-7
|
[7]
|
M. Joo, J. G. Wright, N. N. Hu, et al., “Yin Yang 1 Enhances Cyclooxygenase-2 Gene Expression in Macrophages,” American Journal of Physiology Lung and Cell Molecular Physiology, Vol. 292, No. 5, 2007, pp. L1219L1226. doi:10.1152/ajplung.00474.2006
|
[8]
|
B. D. Lamon, R. K. Upmacis, R. S. Deeb, H. Koyuncu and D. Haijar, “Inducible Nitric Oxide Synthase Gene Deletion Exaggerates MAPK-Mediated Cyclooxygenase2 Induction by Inflammatory Stimuli,” American Journal of Physiology Heart and Circulatory Physiology, Vol. 299, No. 3, 2010, pp. H613-H623.
doi:10.1152/ajpheart.00144.2010
|
[9]
|
Y. Ye, J. D. Martinez, R. J. Perez-Polo, Y. Lin, B. F. Uretsky and Y. Birnbaum, “The Role of eNOS, iNOS, and NF-B in Upregulation and Activation of Cyclooxygenase-2 and Infarct Size Reduction by Atorvastin,” American Journal of Physiology Heart and Circulatory Physiology, Vol. 295, No. 1, 2008, pp. H343-H351.
doi:10.1152/ajpheart.01350.2007
|
[10]
|
S. Cuzzocrea and D. Salvemini, “Molecular Mechanisms Involved in the Reciprocal Regulation of Cyclooxygenase and Nitric Oxide Synthase Enzymes,” Kidney International, Vol. 71, No. 4, 2007, pp. 290-297.
doi:10.1038/sj.ki.5002058
|
[11]
|
B. L. Slomiany and A. Slomiany, “Ghrelin Suppression of Helicobacter Pylori-Induced Gastric Mucosal iNOS Is Mediated through the Inhibition of IKK-β Activation by cNOS-Dependent S-Nitrosylation,” Open Journal of Cell Biology Vol. 1, No. 1, 2011, pp. 1-10. doi:10.4236/ojcb
|
[12]
|
A. V. Grishin, J. Wang, D. A. Potoka, et al., “Lipopolysaccharide Induces Cyclooxygenase-2 in Intestinal Epithelium via a Noncanonical p38 MAPK Pathway,” Journal of Immunology, Vol. 176, No. 1, 2006, pp. 580-588.
|
[13]
|
Y. J. Kang, B. A. Wingerd, T. Arakawa and W. L. Smith, “Cyclooxygenase-2 Gene Transcription in a Macrophage Model of Inflammation,” Journal of Immunology, Vol. 177, No. 11, 2006, pp. 8111-8122.
|
[14]
|
I Cho and S. G. Kim, “A novel Mitogen-Activated Protein Kinase Phosphatase-1 and Glucocorticoid Receptor (GR) Interacting Protein-1-Dependent Combinatorial Mechanism of Gene Transrepression by GR,” Molecular Endocrinology, Vol. 23, No. 1, 2009, pp. 86-99.
doi:10.1210/me.2008-0257
|
[15]
|
M. Caivano, B. Gorgoni, P. Cohen and V. Poli, “The Induction of Cyclooxygenase-2 mRNA in Macrophages Is Biphasic and Requires Both CCAAT Enhancer-Binding Protein β (C/EBPβ) and C/EBPδTranscription Factors,” Journal of Biological Chemistry, Vol. 276, No. 52, 2001, pp. 48693-48701. doi:10.1074/jbc.M108282200
|
[16]
|
D. X. Hou, S. Masuzaki, F. Hashimoto, et al., (2007) “Green Tea Proanthocyanidins Inhibit Cyclooxygenase-2 Expression in LPS-Activated Mouse Macrophages: Molecular Mechanisms and Structure-Activity Relationship,” Archives of Biochemistry and Biophysics, Vol. 460, No. 1, 2007, pp. 67-74. doi:10.1016/j.abb.2007.01.009
|
[17]
|
B. L. Slomiany and A. Slomiany, “Involvement of p38 MAPK-Dependent Activator Protein (AP-1) Activation in Modulation of Gastric Mucosal Inflammatory Responses to Helicobacter pylori by Ghrelin,” Inflammopharmacology, 2012. doi:10.1007/s10787-012-0141-9
|
[18]
|
S. Akira and K. Takeda, “Toll-Like Receptor Signaling,” Nature Reviews Immunology, Vol. 4, No. 7, 2004, pp. 499511. doi:10.1038/nri1391
|
[19]
|
A. M. F. Liu and Y. H. Wong, “G16-Mediated Activation of Nuclear Factor B by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling,” Journal of Biological Chemistry, Vol. 279, No. 51, 2004, pp. 53196-53204. doi:10.1074/jbc.M410196200
|
[20]
|
R. Medzhitov and T. Horng, “Transcriptional Control of the Inflammatory Response,” Nature Reviews Immunology, Vol. 9, No. 10, 2009, pp. 692-703.
doi:10.1038/nri2634
|
[21]
|
B. L. Slomiany and A. Slomiany, “Cytosolic Phospholipase A2 Activation in Helicobacter pylori Lipopolysaccharide-Induced Interference with Gastric Mucin Synthesis,” IUBMB Life, Vol. 58, No. 4, 2006, pp. 217-223.
doi:10.1080/15216540600732021
|
[22]
|
S. P. Newman, J. D. Croxtall, Q. Choudhury and R. J. Flower, “The Coordinate Regulation of Lipocortin 1, COX-2 and cPLA2 by IL-1β in A549 Cells,” Advances in Experimental Medicine and Biology, Vol. 407, 1997, pp. 249-253.
|
[23]
|
M. Hughes-Fulford, R. R. Yjandrawinata, C. F. Li and S. Sayyah, “Arachidonic Acid, an Omega-6 Fatty Acid, Induces Cytoplasmic Phospholipase A2 in Prostate Carcinoma Cells,” Carcinogenesis Vol. 26, No. 9, 2005, pp. 1520-1526. doi:10.1093/carcin/bgi112
|
[24]
|
C. C. Lin, W. N. Lin, W. J. Wang, et al., “Functional Coupling of COX-2 and cPLA2 Induced by ATP in Rat Vascular Smooth Muscle Cells: Role of ERK1/2, p38 MAPK, and NF-κB,” Cardiovascular Research, Vol. 82, No. 3, 2009, pp. 522-531. doi:10.1093/cvr/cvp069
|
[25]
|
N. L. Reynaert, K. Ckless, S. H. Korn, et al., “Nitric Oxide Represses Inhibitory κB Kinase through S-Nitrosylation,” Proceedings of the National Academy of Sciences of theUSA, Vol. 101, No. 24, 2004, pp. 8945-8950.
|
[26]
|
S. F. Kim, D. A. Huri and S. H. Snyder, “Inducible Nitric Oxide Synthase Binds, Snitrosylates, and Activates Cyclooxygenase-2,” Science, Vol. 310, No. 5756, 2005, pp. 1966-1970. doi:10.1126/science.1119407
|
[27]
|
L. Xu, C. Han and T. Wu, “Activation of Cytosolic Phospholipase A2? through Nitric Oxide-Induced S-Nitrosylation. Involvement of Inducible Nitric-Oxide Synthase and Cyclooxygenase-2,” Journal of Biological Chemistry, Vol. 283, No. 6, 2008, pp. 3077 -3087.
doi:10.1074/jbc.M705709200
|
[28]
|
N. D. Perkins, “Integrating Cell-Signalling Pathways with NF-κB and IKK Function,” Nature Reviews Molecular Cell Biology, Vol. 8, No. 1, 2007, pp. 49-62
doi:10.1038/nrm2083
|
[29]
|
B. L. Slomiany and A. Slomiany, “Involvement of Constitutive Nitric Oxide Synthase in Ghrelin-Induced Cytosolic Phospholipase A2 Activation in Gastric Mucosal Cell Protection against Ethanol Cytotoxicity,” Inflammopharmacology, Vol. 17, No. 5, 2009, pp. 245-253.
doi:10.1007/s10787-009-0013-0
|
[30]
|
B. L. Slomiany and A. Slomiany, “Modulation of gastric Mucosal Inflammatory Responses to Helicobacter pylori by Ghrelin: Role of cNOS-Dependent IKK-β S-Nitrosylation in the Regulation of COX-2 Activation,” American Journal of Molecular Biology, Vol. 2, No. 2, 2012, pp. 113-123. doi:10.4236/ajmb
|
[31]
|
B. L. Slomiany and A. Slomiany, “Helicobacter pylori Induces Disturbances in Gastric Mucosal Akt Activation through Inducible Nitric Oxide Synthase-Dependent S-Nitrosylation: Effect of Ghrelin,” ISRN Gastroenterology, 2011, Article ID: 308727.
doi:10.5402/2011/308727
|
[32]
|
S. M. Noha, A. G. Atanasov, D. Schuster, et al., “Discovery of a Novel IKK-β Inhibitor by Ligand-Based Virtual Screening Techniques,” Bioorganic & Medicinal Chemistry Letters, Vol. 21, No. 1, 20011, pp. 577-583.
|
[33]
|
S. R. Jaffrey, H. Erdjument-Bromage, D. Ferris, P. Tempst and S. H. Snyder, “Protein S-Nitrosylation: A Physiological Signal for Neuronal Nitric Acid,” Nature Cell Biology, Vol. 3, No. 2, 2001, pp. 193-197.
doi:10.1038/35055104
|
[34]
|
M. T. Forrester, M. W. Foster and J. S. Stamler, “Assessment and Application of the Biotin Switch Technique for Examining Protein S-Nitrosylation under Conditions of Pharmacologically Induced Oxidative Stress,” Journal of Biological Chemistry, Vol. 282, No. 19, 2007, pp. 1397713983. doi:10.1074/jbc.M609684200
|
[35]
|
K. W. Kang, S. Y. Choi, M. K. Cho, C. C. Lee and S. G. Kim, “Thrombin Induces Nitric-Oxide Synthase via Ga12/13Coupled Protein Kinase C-Dependent I-κBα and JNK-Mediated I-κBα Degradation,” Journal of Biological Chemistry, Vol. 278, No. 19, 2003, pp. 17368-17378.
doi:10.1074/jbc.M300471200
|
[36]
|
T. Hirabayashi and T. Shimizu, “Localization and Regulation of Cytosolic Phospholipase A2,” Biochimica et Biophysica Acta, Vol. 1488, No. 1-2, 2000, pp. 124-138.
doi:10.1016/S1388-1981(00)00115-3
|
[37]
|
P. Lodeiro, M. Theodoropoulou, M. Pardo, F. F. Casanueva and J. P. Camina, “c-Src Regulates Akt Signaling in Response to Ghrelin via b-Arrestin Signaling-Independent and Dependent Mechanism,” PLoS ONE, Vol. 4, No. 3, 2009, p. e4686. doi:10.1371
|
[38]
|
W. Wu, Z. Sun, J. Wu, et al., “Trihydrophobin 1 Phosphorylatio by c-Src Regulates MAPK/ERK Signaling and Cell Migration,” PLoS One, Vol. 7, No. 1, 2012, p. e29920.
doi:10.1371/journal.pone.0029920
|
[39]
|
X. Xu, B. S. Jhun, C. H. Ha and Z. G. Jin, (2008) “Molecular Mechanisms of Ghrelin-Mediated Endothelial Nitric-Oxide Synthase Activation,” Endocrinology, Vol. 149, No. 8, 2008, pp. 4183-4192.
doi:10.1210/en.2008-0255
|